Novo Nordisk deal lets Hims sell Wegovy and Ozempic, drops lawsuit - USA Today

USA Today
March 9, 2026
2 views
3 min read

Quick Insights

The Bottom Line

Novo Nordisk and Hims & Hers settled a lawsuit, allowing Hims to sell branded Wegovy and Ozempic.

How This Affects You

If you use Hims & Hers for telehealth, you may now have access to branded GLP-1 medications like Wegovy and Ozempic for weight loss or diabetes.

AI Summary

Novo Nordisk and Hims & Hers have settled their legal dispute, allowing Hims to offer GLP-1 medications like Wegovy and Ozempic through its platform. The agreement concludes a lawsuit Novo Nordisk filed against Hims & Hers for alleged trademark infringement and false advertising related to compounded GLP-1 drugs. Under the terms, Hims & Hers will now source the branded medications directly from Novo Nordisk for its telehealth patients. This resolution provides Hims & Hers with a legitimate supply of popular weight-loss and diabetes treatments, while Novo Nordisk ensures its branded products are distributed through authorized channels. The deal could expand access to these medications for Hims & Hers' customers.

What's Being Done

Novo Nordisk and Hims & Hers settled a lawsuit, allowing Hims to offer GLP-1 medications like Wegovy and Ozempic.

Following this story?

Get notified when new coverage appears

Should this be getting more attention?

You Might Have Missed

Related stories from different sources and perspectives

Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration
Corporate

Novo Nordisk drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration

The companies on Monday announced a partnership in which Hims & Hers will sell Novo Nordisk's medications at "self-pay prices."

PBS NewsHourMar 9
Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration - AP News
Corporate

Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration - AP News

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxQMnQ1d1I3MmlaaC1ZcGJic1lwc3pCMTV4N2NicDQ3dnZTV1JlR0FrUTFZRHNEVWFWWnNHNnJIMTZveXF2bXpWY09QT1BwZWd3STlhS2hpOHRNVEQ3cThmTWZZWFBVLURWWHl1TC1Vb3U0T2JPZk1iYVNmYVNBVXJaZm1tNno1czZRRFJ6Wjh0NHBSdU9EVTZWd1YtUGtRX3BFZUcw?oc=5" target="_blank">Hims & Hers Health and Novo Nordisk end lawsuit over weight loss medications, enter collaboration</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsMar 9
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Health

FDA warns Novo Nordisk over unreported potential Ozempic side effects

The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.

CBS NewsMar 10
FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s
Health

FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications, popularly known as Ozempic and Wegovy. The FDA wrote in a March 5 letter that it observed “serious violations” of reporting requirements during…

The HillMar 10
Judge urges states to settle Live Nation claims after US strikes deal but states say no chance - AP News
Corporate

Judge urges states to settle Live Nation claims after US strikes deal but states say no chance - AP News

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxQVVQtblR3NVc3bkFlSjd2WUt6RzFhVnVEc2dQbkZYdWZ4dFZpS2RUSTRES0VWSjhNcEVDU2oybDlVbmhRMU1HNmh0ZGZJSy03elZzR0R2d2VkWnJVcFc2U2lEc1IzYzdER0U2SDI4VzV3XzF5eTd1b3F1UXZhdG91M290TWFGeWxTek9RZmxEdDZXQWlCRXhHWlpqb0R2eDBDMkE?oc=5" target="_blank">Judge urges states to settle Live Nation claims after US strikes deal but states say no chance</a>&nbsp;&nbsp;<font color="#6f6f6f">AP News</font>

AP NewsMar 10
Exclusive: Chevron, Shell closing in on first big oil production deals in Venezuela since US captured Maduro, sources say - Reuters
Corporate

Exclusive: Chevron, Shell closing in on first big oil production deals in Venezuela since US captured Maduro, sources say - Reuters

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxOcTlDdXVQdjFycDUyZm9memlqZHd3ZkFpVEhsb25TXzJqdkVQc1FMZGFyNUVyRDdDa09EWU9xYVN4VHNRR3MwTzVJbFB1bjd3aks5dmZRd2lLUGhJaUZ3aUp5YWJMM3RyamlLU09WTkRobGg1aERkTHk1MkVWNlRHa0RzbFVYX0xUaXRvUmhWVHlWSnBPQ2VmazluNUpSc3VuSTA3WllLejNadndyRWZLRzFnU0J6dWRZLUJZRWluQmQ0aUZmM2ZZby1BbHc?oc=5" target="_blank">Exclusive: Chevron, Shell closing in on first big oil production deals in Venezuela since US captured Maduro, sources say</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

ReutersMar 10
Read Next
US, Japan agree on their roles in potential nuclear power project, Westinghouse says - Reuters
Corporate

US, Japan agree on their roles in potential nuclear power project, Westinghouse says - Reuters

<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQSWtjM1lUQW12N1hJQlBkU2d6V2o5THBxbWtWMWJFOHhzRXd0V3ljNlB6U1hFVDVVT3YyVDJaclByUTJ0dWIwbk9ZMUFIaFVSVDdHZ1dYZjVLQTBlNVFjTURZd1NrNWJjd19BcENoYUJXOVcwaUczRFNXSnVYOW4zT0ZLRi1PbXFReUhvVm12Y1BoaHpIUWQ2XzRNNTV1ZVo0LVdZcmZaRkZKaEVLX0VBSW9scUtWY0U2N3ZPQjBQMW1ubWtWcFpj?oc=5" target="_blank">US, Japan agree on their roles in potential nuclear power project, Westinghouse says</a>&nbsp;&nbsp;<font color="#6f6f6f">Reuters</font>

Continue reading

Did this story change how you see things?

Stories like this only matter when people see them. Help us get verified journalism in front of more eyes.

Share this story

Get the daily digest

Save for later

The Verity Ledger curates verified investigative journalism from trusted sources only.

See our sources